Neurocrine Biosciences, Inc.
MX ˙ BMV ˙ US64125C1099
SecurityMX:NBIX / Neurocrine Biosciences, Inc.
InstitutionAllianz Asset Management GmbH
Latest Disclosed Ownership14,196 shares
Latest Disclosed Value $ 1,870,181
Allianz Asset Management GmbH reports 11.75% decrease in ownership of NBIX / Neurocrine Biosciences, Inc.

On May 11, 2026 - Allianz Asset Management GmbH filed a 13F-HR form disclosing ownership of 14,196 shares of Neurocrine Biosciences, Inc. (MX:NBIX) valued at $1,870,181 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 16,086 shares of Neurocrine Biosciences, Inc.. This represents a change in shares of -11.75% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 14,196 -1,890 -11.75 1,870 -18.02 0.0007
2026-02-11 2025-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 16,086 1,118 7.47 2,281 8.57 0.0023
2025-11-04 2025-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 14,968 -1,584 -9.57 2,101 1.01 0.0023
2025-07-28 2025-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 16,552 -8,486 -33.89 2,080 -24.88 0.0025
2025-05-05 2025-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 25,038 -3,380 -11.89 2,769 -28.62 0.0036
2025-02-03 2024-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 28,418 69 0.24 3,879 18.77 0.0052
2024-11-13 2024-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 28,349 6,676 30.80 3,266 9.49 0.0046
2024-08-13 2024-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 21,673 -5,795 -21.10 2,984 -21.25 0.0044
2024-05-14 2024-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 27,468 -2,140 -7.23 3,788 -2.90 0.0058
2024-02-12 2023-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 29,608 -52,518 -63.95 3,901 -57.78 0.0064
2023-11-13 2023-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 82,126 -1,746 -2.08 9,239 16.82 0.0156
2023-08-14 2023-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 83,872 -157,121 -65.20 7,909 -67.58 0.0142
2023-05-11 2023-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 240,993 -9,936 -3.96 24,393 -18.61 0.0433
2023-02-13 2022-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 250,929 73,619 41.52 29,971 59.14 0.0582
2022-11-08 2022-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 177,310 -68,354 -27.82 18,833 -21.36 0.0383
2022-08-12 2022-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 245,664 -20,358 -7.65 23,947 -3.98 0.0227
2022-05-13 2022-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 266,022 67,248 33.83 24,939 47.35 0.0186
2022-02-11 2021-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 198,774 -22,653 -10.23 16,925 -20.30 0.0118
2021-11-10 2021-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 221,427 58,850 36.20 21,237 34.22 0.0165
2021-08-16 2021-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 162,577 84,096 107.15 15,822 107.31 0.0135
2021-05-13 2021-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 78,481 906 1.17 7,632 2.64 0.0074
2021-02-16 2020-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 77,575 26,844 52.91 7,436 52.44 0.0073
2020-11-13 2020-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 50,731 10,046 24.69 4,878 -1.73 0.0057
2020-08-14 2020-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 40,685 -3,172 -7.23 4,964 30.77 0.0057
2020-05-14 2020-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 43,857 -12,239 -21.82 3,796 -37.04 0.0051
2020-02-13 2019-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 56,096 -57,135 -50.46 6,029 -40.92 0.0055
2019-11-13 2019-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 113,231 -44,625 -28.27 10,205 -23.43 0.0100
2019-08-08 2019-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 157,856 -6,749 -4.10 13,328 -8.10 0.0124
2019-05-13 2019-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 164,605 -121,765 -42.52 14,502 -28.74 0.0144
2019-04-02 2018-12-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 286,370 -81,536 -22.16 20,352 -55.01 0.0223
2019-02-13 2018-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 286,370 -81,536 20,352
2019-04-09 2018-09-30 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 367,906 -1,663 -0.45 45,235 24.59 0.0411
2018-11-13 2018-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 367,906 -1,663 45,235
2019-04-09 2018-06-30 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 369,569 -26,531 -6.70 36,306 10.52 0.0353
2018-08-13 2018-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 369,569 -26,531 36,306
2019-04-09 2018-03-31 13F/A-2 NEUROCRINE BIOSCIENCES COM 64125C109 396,100 45,775 13.07 32,849 20.85 0.0314
2018-05-23 2018-03-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 396,100 0 32,849 0.0314
2018-05-14 2018-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 396,100 45,775 32,849
2019-04-17 2017-12-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 350,325 310,214 773.39 27,182 1,005.86 0.0215
2018-02-13 2017-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 350,325 310,214 27,182
2019-04-17 2017-09-30 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 40,111 75 0.19 2,458 32.79 0.0021
2017-11-13 2017-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 40,111 75 2,458
2019-04-17 2017-06-30 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 40,036 40,036 1,851 0.0018
2017-08-14 2017-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 40,036 40,036 1,851
2019-04-17 2017-03-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 0 -224,869 -100.00 0 -100.00
2019-04-17 2016-12-31 13F/A-2 NEUROCRINE BIOSCIENCES COM 64125C109 224,869 -3,876 -1.69 8,702 -24.53 0.0078
2017-03-14 2016-12-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 224,869 0 8,702 0.0078
2017-02-13 2016-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 224,869 8,702
2019-04-17 2016-09-30 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 228,745 -64,431 -21.98 11,531 -13.46 0.0113
2016-11-14 2016-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 228,745 -64,431 11,531
2017-01-24 2016-06-30 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 293,176 -11,231 -3.69 13,324 10.67 0.0143
2016-08-12 2016-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 293,176 13,324
2016-05-13 2016-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 304,407 95,767 45.90 12,039 2.09 0.0138
2017-01-24 2015-12-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 208,640 18,600 9.79 11,793 55.95 0.0133
2016-02-16 2015-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 208,640 11,793
2017-01-24 2015-09-30 13F/A-2 NEUROCRINE BIOSCIENCES COM 64125C109 190,040 26,165 15.97 7,562 -3.39 0.0090
2015-11-20 2015-09-30 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 190,040 0 7,562 0.0079
2015-11-13 2015-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 190,040 7,562
2015-09-22 2015-06-30 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 163,875 -103,664 -38.75 7,827 -26.33 0.0084
2015-08-14 2015-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 163,875 7,827
2017-01-24 2015-03-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 267,539 -192,881 -41.89 10,624 3.30 0.0121
2015-05-15 2015-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 267,539 10,623,974
2015-02-17 2014-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 460,420 205,210 80.41 10,285 157.13 0.0114
2014-11-14 2014-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 255,210 -23,000 -8.27 4,000 -3.08 0.0048
2014-08-13 2014-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 278,210 -3,190 -1.13 4,127 -8.92 0.0052
2014-05-28 2014-03-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 281,400 55,000 24.29 4,531 114.23 0.0054
2014-05-14 2014-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 281,400 4,531
2014-02-13 2013-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 226,400 0 0.00 2,115 -17.48 0.0027
2013-11-14 2013-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 226,400 -205,100 -47.53 2,563 -55.60 0.0034
2013-08-14 2013-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 431,500 431,500 5,773 0.0082
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.